Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Control, Open-label, Multicenter, Phase II/III Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients

NCT03758014 is registered in ClinicalTrials.gov with Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd as lead sponsor.

NCT NCT03758014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03758014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Control, Open-label, Multicenter, Phase II/III Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients
Lead sponsor
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 27, 2018
Completion date
April 30, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gbm